CORONAVIRUS IMMUNOGEN COMPOSITIONS AND THEIR USES
The disclosure provides compositions and methods comprising circular polyribonucleotides comprising a sequence encoding a coronavirus immunogen, and compositions and methods comprising linear polyribonucleotides comprising a sequence encoding one or more coronavirus immunogens. Compositions and meth...
Saved in:
| Main Authors | , , , , , , , |
|---|---|
| Format | Patent |
| Language | English French |
| Published |
01.06.2023
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | The disclosure provides compositions and methods comprising circular polyribonucleotides comprising a sequence encoding a coronavirus immunogen, and compositions and methods comprising linear polyribonucleotides comprising a sequence encoding one or more coronavirus immunogens. Compositions and methods are provided that are related to generating polyclonal antibodies, for example, using the disclosed circular polyribonucleotides or the disclosed linear polyribonucleotides.
L'invention concerne des compositions et des procédés comprenant des polyribonucléotides circulaires comportant une séquence codant pour un immunogène de coronavirus, et des compositions et des procédés comprenant des polyribonucléotides linéaires comportant une séquence codant pour un ou plusieurs immunogènes de coronavirus. L'invention concerne également des compositions et des procédés qui sont associés à la génération d'anticorps polyclonaux, par exemple, à l'aide des polyribonucléotides circulaires décrits ou des polyribonucléotides linéaires décrits. |
|---|---|
| AbstractList | The disclosure provides compositions and methods comprising circular polyribonucleotides comprising a sequence encoding a coronavirus immunogen, and compositions and methods comprising linear polyribonucleotides comprising a sequence encoding one or more coronavirus immunogens. Compositions and methods are provided that are related to generating polyclonal antibodies, for example, using the disclosed circular polyribonucleotides or the disclosed linear polyribonucleotides.
L'invention concerne des compositions et des procédés comprenant des polyribonucléotides circulaires comportant une séquence codant pour un immunogène de coronavirus, et des compositions et des procédés comprenant des polyribonucléotides linéaires comportant une séquence codant pour un ou plusieurs immunogènes de coronavirus. L'invention concerne également des compositions et des procédés qui sont associés à la génération d'anticorps polyclonaux, par exemple, à l'aide des polyribonucléotides circulaires décrits ou des polyribonucléotides linéaires décrits. |
| Author | SIGOVA, Alla Alexeevna DE BOER, Alexandra Sophie MELFI, Michael Donato MOSAHEB, Mohammad Mubeen NELSON, Jennifer A KAHVEJIAN, Avak LEE, Soohyun ECHELARD, Yann Paul Guy Régis |
| Author_xml | – fullname: SIGOVA, Alla Alexeevna – fullname: MELFI, Michael Donato – fullname: NELSON, Jennifer A – fullname: KAHVEJIAN, Avak – fullname: DE BOER, Alexandra Sophie – fullname: ECHELARD, Yann Paul Guy Régis – fullname: LEE, Soohyun – fullname: MOSAHEB, Mohammad Mubeen |
| BookMark | eNrjYmDJy89L5WQwdPYP8vdzDPMMCg1W8PT1DfXzd3f1U3D29w3wD_YM8fT3C1Zw9HNRCPFw9QxSCA12DeZhYE1LzClO5YXS3AzKbq4hzh66qQX58anFBYnJqXmpJfHh_kYGRsYGlmaWlgaOhsbEqQIAJlAptg |
| ContentType | Patent |
| DBID | EVB |
| DatabaseName | esp@cenet |
| DatabaseTitleList | |
| Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Chemistry Sciences |
| DocumentTitleAlternate | COMPOSITIONS IMMUNOGÈNES DE CORONAVIRUS ET LEURS UTILISATIONS |
| ExternalDocumentID | WO2023096990A1 |
| GroupedDBID | EVB |
| ID | FETCH-epo_espacenet_WO2023096990A13 |
| IEDL.DBID | EVB |
| IngestDate | Fri Oct 18 05:52:59 EDT 2024 |
| IsOpenAccess | true |
| IsPeerReviewed | false |
| IsScholarly | false |
| Language | English French |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-epo_espacenet_WO2023096990A13 |
| Notes | Application Number: WO2022US50893 |
| OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230601&DB=EPODOC&CC=WO&NR=2023096990A1 |
| ParticipantIDs | epo_espacenet_WO2023096990A1 |
| PublicationCentury | 2000 |
| PublicationDate | 20230601 |
| PublicationDateYYYYMMDD | 2023-06-01 |
| PublicationDate_xml | – month: 06 year: 2023 text: 20230601 day: 01 |
| PublicationDecade | 2020 |
| PublicationYear | 2023 |
| RelatedCompanies | FLAGSHIP PIONEERING INNOVATION VI, LLC |
| RelatedCompanies_xml | – name: FLAGSHIP PIONEERING INNOVATION VI, LLC |
| Score | 3.4686086 |
| Snippet | The disclosure provides compositions and methods comprising circular polyribonucleotides comprising a sequence encoding a coronavirus immunogen, and... |
| SourceID | epo |
| SourceType | Open Access Repository |
| SubjectTerms | CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| Title | CORONAVIRUS IMMUNOGEN COMPOSITIONS AND THEIR USES |
| URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230601&DB=EPODOC&locale=&CC=WO&NR=2023096990A1 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_GFPVNp-LHlIKyt2Jjs348DOnS1lZoM7p27m0ssYIg3XAV_32vXad72luSg8sH3McvubsA3L_JyurrmqoJm6rUIHPVeswNlfTn1EQLbb7LKlE4io0goy_T_rQFn5tcmLpO6E9dHBElSqK8l7W-Xv5fYrl1bOXqQXzg0OLJTwdur0HHlT-N2NgdDrwRdznrMYa4rRcna5ptoO51ECvtoSNtVvLgTYZVXspy26j4x7A_Qn5FeQKtvOjAIdv8vdaBg6h58sZmI32rUyCMJzx2JmGSjZUwirKYP3uxwng04uOwzgdWnNhV0sALEyVDTXkGd76XskDFuWd_W5298u2F6ufQLhZFfgGKaRGT5MKWxBTUsg2h6VLaQhIyzyWl-iV0d3G62k2-hqOquw6B6kK7_PrOb9DYluK2PqNfXqd9Gg |
| link.rule.ids | 230,309,783,888,25576,76876 |
| linkProvider | European Patent Office |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3fT8IwEL4QNOKbokYUdYmGt0XqysYeiIFuuClrydiQN0LrTEzMIDLjv-9tgPLEW9NLrj-Su---9q4FuHtTOeobTb0pbapTk8z09kNi6qQ1oxYitPWu8kLhgJteTJ8nrUkJPje1MMU7oT_F44hoUQrtPSv89eL_EMspciuX9_IDu-aP_ajjNNbsOI-nkRs7vY47FI5gDcaQtzV4uJLZJvreLnKlPQyyrdwe3HEvr0tZbINK_wj2h6gvzY6hlKRVqLDN32tVOAjWV97YXFvf8gQIE6Hg3bEfxiPND4KYiyeXa0wEQzHyi3pgrcsdLfJcP9Ri9JSncNt3I-bpOPb0b6nTV7E9UeMMyuk8Tc5Bs9rEIom0FbEkbdumbBpK2VIRMksUpUYN6rs0XewW30DFi4LBdODzl0s4zEWrdKg6lLOv7-QKgTeT18V-_QJoI4AN |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=CORONAVIRUS+IMMUNOGEN+COMPOSITIONS+AND+THEIR+USES&rft.inventor=SIGOVA%2C+Alla+Alexeevna&rft.inventor=MELFI%2C+Michael+Donato&rft.inventor=NELSON%2C+Jennifer+A&rft.inventor=KAHVEJIAN%2C+Avak&rft.inventor=DE+BOER%2C+Alexandra+Sophie&rft.inventor=ECHELARD%2C+Yann+Paul+Guy+R%C3%A9gis&rft.inventor=LEE%2C+Soohyun&rft.inventor=MOSAHEB%2C+Mohammad+Mubeen&rft.date=2023-06-01&rft.externalDBID=A1&rft.externalDocID=WO2023096990A1 |